StonvexLoading…
StonvexCore line items from MCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q3 2022 2022-09-29 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 | Q3 2021 2021-09-30 |
|---|---|---|---|---|---|
Revenue | $212.06M | $489.62M | $314.93M | $124.63M | $277.56M |
Operating Income | Not available | $11.04M | $2.10M | $-16.80M | $-55.50M |
Net Income | Not available | $-2.65M | $-5.94M | $-14.90M | $-49.74M |
EPS (Diluted) | $0.29 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $1.12B | $1.17B | $1.14B | $1.19B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $10.53M | $57.74M | $19.43M | $8.63M |
Free Cash Flow OCF − CapEx | Not available | $32.88M | $38.89M | $-91.00K | $-7.06M |
Shares Outstanding | Not available | 31.48M | 31.47M | 31.45M | 31.34M |